Share Facebook Twitter Email Telegram WhatsApp There is a major shortage of over-the-counter treatments for respiratory illnesses and bacterial infections…Read More
Eisai: Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by European Medicines AgencyJanuary 28, 2023